The world’s biggest pharmaceutical company Pfizer has rolled out its anti-smoking drug Champix, which lessens nicotine craving as well as the pleasure of smoking.
Having global sales of around $1 billion, Champix is priced at Rs 9500 for a 12- week treatment regime by Pfizer.
At first, the company is launching Champix in 17 cities at a lower price than the US and the European markets. The 12-week Champix prescription course will cost just Rs 9,500..